User talk:Paintherapeutics

Remoxy

Remoxy is a unique, long-acting formulation of oral oxycodone for moderate to severe chronic pain, designed to resist common methods of prescription drug misuse and abuse.

Pain Therapeutics and King Pharmaceuticals announced on August 12, 2008 that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for Remoxy and granted Priority Review.

Remoxy is intended to meet the needs of physicians who appropriately prescribe opioid painkillers and who seek to minimize risks of drug diversion, abuse or accidental patient misuse. Published data also show that freezing, crushing or submerging Remoxy in high-proof alcohol for hours at a time releases just a fraction of oxycodone at time points when abusers presumably expect to get high.